Literature DB >> 2000260

Newly identified forms of electron transfer flavoprotein deficiency in two patients with glutaric aciduria type II.

S Yamaguchi1, T Orii, Y Suzuki, K Maeda, M Oshima, T Hashimoto.   

Abstract

Newly identified forms of electron transfer flavoprotein (ETF) deficiency in two patients with glutaric aciduria type II (GA II) were described. GA II has been attributed to a defect of either ETF or ETF dehydrogenase, resulting in multiple acyl-CoA dehydrogenation deficiency. ETF is a mitochondrial flavoprotein consisting of an alpha-subunit, alpha-ETF, and a beta-subunit, beta-ETF. We used pulse-chase experiments to examine the biosynthesis of ETF in fibroblasts from two patients with GA II. Patient 1 was a boy with the neonatal onset form, but without congenital anomalies, who is living at age 2 y. A defect of beta-ETF biosynthesis was noted in this patient. Patient 2 was a boy with the neonatal onset form with congenital anomalies who died on the 3rd postnatal day. He presented with a peculiar face and polycystic kidneys. In patient 2, both alpha- and beta-ETF were synthesized, but both the subunits were rapidly degraded. The lability of ETF was considered to be the cause of GA II in this patient. These two cases appear to be new forms of ETF deficiency in GA II.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000260     DOI: 10.1203/00006450-199101000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Therapeutic trial in the first three Asian cases of ethylmalonic encephalopathy: response to riboflavin.

Authors:  H R Yoon; S H Hahn; Y M Ahn; S H Jang; Y J Shin; E H Lee; K H Ryu; B L Eun; P Rinaldo; S Yamaguchi
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

2.  Lipid-storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency.

Authors:  R K J Olsen; M Pourfarzam; A A M Morris; R C Dias; I Knudsen; B S Andresen; N Gregersen; S E Olpin
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 3.  Mammalian mitochondrial beta-oxidation.

Authors:  S Eaton; K Bartlett; M Pourfarzam
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

4.  Glutaric acidemia type II. Heterogeneity in beta-oxidation flux, polypeptide synthesis, and complementary DNA mutations in the alpha subunit of electron transfer flavoprotein in eight patients.

Authors:  E Freneaux; V C Sheffield; L Molin; A Shires; W J Rhead
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  Stroke, hemiparesis and deficient mitochondrial beta-oxidation.

Authors:  L Vallée; M Fontaine; J P Nuyts; G Ricart; I Krivosic; P Divry; C Vianey-Saban; M Lhermitte; J Vamecq
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

6.  Glutaric acidemia type II patient with thalassemia minor and novel electron transfer flavoprotein-A gene mutations: A case report and review of literature.

Authors:  Neslihan Yildirim Saral; Fehime Benli Aksungar; Cigdem Aktuglu-Zeybek; Julide Coskun; Ozlem Demirelce; Mustafa Serteser
Journal:  World J Clin Cases       Date:  2018-11-26       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.